These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical pharmacokinetics of lorazepam: a review. Kyriakopoulos AA; Greenblatt DJ; Shader RI J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):16-23. PubMed ID: 30762 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. Greenblatt DJ; Shader RI; Franke K; MacLaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E J Pharm Sci; 1979 Jan; 68(1):57-63. PubMed ID: 31453 [No Abstract] [Full Text] [Related]
10. Placebo-controlled comparative study of the anxiolytic activity and of the pharmacokinetics of oral and sublingual lorazepam in generalized anxiety. Spénard J; Caillé G; de Montigny C; Vézina M; Ouellette J; Larivière L; Trudel F Biopharm Drug Dispos; 1988; 9(5):457-64. PubMed ID: 3066417 [TBL] [Abstract][Full Text] [Related]
11. Lorazepam kinetics in the elderly. Greenblatt DJ; Allen MD; Locniskar A; Harmatz JS; Shader RI Clin Pharmacol Ther; 1979 Jul; 26(1):103-13. PubMed ID: 36252 [TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability in humans for oral tablets and solutions of lormetazepam. Zecca L; Reina L; Scaglione F; Ferrario P; Pirola R; Ceccarelli G; Ciampini M; Fraschini F Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762 [TBL] [Abstract][Full Text] [Related]
13. Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation. Greenblatt DJ; Allen MD; MacLaughlin DS; Huffman DH; Harmatz JS; Shader RI J Pharmacokinet Biopharm; 1979 Apr; 7(2):159-79. PubMed ID: 20218012 [TBL] [Abstract][Full Text] [Related]
14. Disposition pharmacokinetics of lorazepam in the rabbit. Nielsen-Kudsk F; Jakobsen P Acta Pharmacol Toxicol (Copenh); 1980 May; 46(5):388-91. PubMed ID: 6103631 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humans. Nielsen-Kudsk F; Jensen TS; Magnussen I; Jakobsen P; Jensen PB; Mondrup K; Petersen T Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):121-7. PubMed ID: 6133404 [TBL] [Abstract][Full Text] [Related]
16. Single dose sublingual testosterone and oral sildenafil vs. a dual route/dual release fixed dose combination tablet: a pharmacokinetic comparison. Bloemers J; van Rooij K; de Leede L; Frijlink HW; Koppeschaar HP; Olivier B; Tuiten A Br J Clin Pharmacol; 2016 Jun; 81(6):1091-102. PubMed ID: 26804967 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of oxazepam and lorazepam. Greenblatt DJ Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic correlates of modified absorption: studies with lormetazepam. Pierce DM; Franklin RA; Harry TV; Nicholson AN Br J Clin Pharmacol; 1984 Jul; 18(1):31-5. PubMed ID: 6146348 [TBL] [Abstract][Full Text] [Related]
19. Interaction of cimetidine with oxazepam, lorazepam, and flurazepam. Greenblatt DJ; Abernethy DR; Koepke HH; Shader RI J Clin Pharmacol; 1984 Apr; 24(4):187-93. PubMed ID: 6144699 [TBL] [Abstract][Full Text] [Related]